Fasting hyperinsulinemia is a potential mediator for breast carcinogenesis (88), and insulin and insulin-like growth factor-1 (IGF-1) may synergistically increase BC risk (70, 89). The gene discussed is IGF1; the disease is hyperinsulinism.